Based globally with a presence in Arizona, Jazz Pharmaceuticals is working to change what is possible for people living with rare and serious diseases, particularly in areas where treatment options are limited and the consequences for patients and families can be profound.
What Impact Is Jazz Pharmaceuticals Aiming to Create?
At Jazz, they are working to change what is possible for people living with rare and serious diseases, particularly in areas where treatment options are limited and the consequences for patients and families can be profound. Their purpose is to innovate to transform the lives of patients and their families, and they bring that purpose to life by developing differentiated medicines, generating evidence that can inform clinical practice, and supporting patients throughout their treatment journey. Their goal is to translate scientific progress into meaningful and lasting improvements in care.
What Key Need Is Jazz Pharmaceuticals Focused on Addressing?
Rare diseases alone affect more than 300 million people worldwide, yet many patients still face delayed diagnoses, limited treatment options, and significant barriers to care. In some rare diseases, patients may have few or no approved treatment options available. Jazz has strengthened their commitment to becoming a leading innovator in rare diseases, where the need for new treatment options remains especially great. They are focused on advancing medicines, generating new data, and improving support for people living with these conditions across rare epilepsies, cancers, and sleep disorders.
Why Is Addressing This Unmet Need So Critical?
Behind every diagnosis is a person, a family, and often a caregiver whose life has been changed dramatically. For people living with serious disease, time has a different meaning. A development timeline can represent more time without an effective option, continued uncertainty for a family, or the progression of a disease that can’t be reversed. That reality is particularly acute in rare diseases, where people may spend years seeking a diagnosis and may have limited treatment choices once they receive one. Jazz believes innovation matters most when it changes what’s possible for patients, and that belief drives them to make clear choices, focus resources on the opportunities with the greatest potential, and follow through with the discipline required to turn promising science into better care.
How Is Jazz Pharmaceuticals’ Approach Making a Meaningful Impact?
What differentiates Jazz is their focus. They start with patients and use data, technology, and artificial intelligence to help accelerate target discovery, strengthen development decisions, and better understand patient journeys. These capabilities allow them to generate insights faster, focus resources where they believe they can make the greatest difference, and make better-informed decisions across the development process from early discovery through patient support. Today, they engage patients, caregivers, and advocates through 10 dedicated steering committees that provide direct input into development programs, patient support initiatives, and educational resources.
How Has Being Based in Arizona Supported Jazz Pharmaceuticals’ Growth?
Arizona has been a place where Jazz can feel momentum and a commitment to growing the biopharma sector. While Jazz operates globally with teams working across many locations in the U.S., being part of a community that brings together innovators, researchers, entrepreneurs, and healthcare leaders who are passionate about improving lives has been meaningful. There’s a strong sense of possibility in Arizona that aligns closely with how Jazz thinks about their work and the patients and families they serve.
What Does the Future Look Like for Jazz Pharmaceuticals?
The future for Jazz is one of focused growth and continued transformation. They are working toward their ambition to become a leading innovator in rare disease, advancing their pipeline across sleep, epilepsies, and oncology, and investing in opportunities where Jazz can make a meaningful difference. They will continue to evolve their portfolio through research and development, lifecycle innovation, and targeted business development, with some of their most important work still ahead.
Responses attributed to Renee Gala, Jazz Pharmaceuticals.